Furthermore, TMEM44‐AS1 promotes GC cell proliferation but suppresses their apoptosis after 5‐FU treatment by sponging miR‐2355‐5p, leading to PPP1R13L up‐regulation and the consequent downregulation of the P53 signaling pathway. Here, TMEM44 is linked to gastric cancer.